Index of /wp-content/uploads/2023/12

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1.-Draft-Scheme-of-Arrangement.pdf2025-05-06 14:18 9.7M 
[ ]2.-Certificate-for-non-applicability-of-valuation-report.pdf2025-05-06 14:18 185K 
[ ]3.-Audit-Committee-Report.pdf2025-05-06 14:18 858K 
[ ]4.-Shareholding-Pattern-Pre-and-Post-of-unlisted-entities.pdf2025-05-06 14:18 3.5M 
[ ]5.-Audited-Financials-of-last-3-years-of-unlisted-entities.pdf2025-05-06 14:18 1.0M 
[ ]6.-Accounting-treatment-Certificate.pdf2025-05-06 14:18 8.8M 
[ ]7.-Compliance-Report.pdf2025-05-06 14:18 203K 
[ ]8.-ID-Committee-Report.pdf2025-05-06 14:18 915K 
[ ]9.-Past-Default-of-listed-debt-obligation.pdf2025-05-06 14:18 164K 
[ ]10.-NOC.pdf2025-05-06 14:18 86K 
[ ]11.-Undertaking-certified-by-Auditor_Para-10.pdf2025-05-06 14:18 250K 
[IMG]20231205_115920.jpg2025-05-06 14:18 3.5M 
[IMG]20231226_212309.jpg2025-05-06 14:18 966K 
[IMG]1701358495736.jpg2025-05-06 14:18 112K 
[ ]Audited-IFRS-report-2021_en_no_signature_.pdf2025-05-06 14:18 10M 
[ ]BMW-Disposal-Summary-Nov-23-Sun-Pharma.pdf2025-05-06 14:18 157K 
[IMG]Bonista-PF-batch.jpeg2025-05-06 14:18 76K 
[IMG]DSC03370-150x150.jpg2025-05-06 14:18 6.8K 
[IMG]DSC03370-300x200.jpg2025-05-06 14:18 15K 
[IMG]DSC03370-400x250.jpg2025-05-06 14:18 22K 
[IMG]DSC03370-400x284.jpg2025-05-06 14:18 24K 
[IMG]DSC03370-400x516.jpg2025-05-06 14:18 36K 
[IMG]DSC03370-480x320.jpg2025-05-06 14:18 31K 
[IMG]DSC03370-510x382.jpg2025-05-06 14:18 38K 
[IMG]DSC03370-768x512.jpg2025-05-06 14:18 65K 
[IMG]DSC03370-980x653.jpg2025-05-06 14:18 96K 
[IMG]DSC03370-1080x675.jpg2025-05-06 14:18 108K 
[IMG]DSC03370-1080x720.jpg2025-05-06 14:18 112K 
[IMG]DSC03370-1280x854.jpg2025-05-06 14:18 147K 
[IMG]DSC03370-1536x1024.jpg2025-05-06 14:18 195K 
[IMG]DSC03370-2048x1365.jpg2025-05-06 14:18 306K 
[IMG]DSC03370-2880x1800.jpg2025-05-06 14:18 493K 
[IMG]DSC03370-scaled.jpg2025-05-06 14:18 434K 
[IMG]DSC03370.jpg2025-05-06 14:18 7.5M 
[ ]Document-June-2023.pdf2025-05-06 14:18 919K 
[IMG]IMG20231225131051.jpg2025-05-06 14:18 2.9M 
[IMG]IMG_2937.jpeg2025-05-06 14:18 285K 
[IMG]IMG_6715.jpeg2025-05-06 14:18 1.0M 
[IMG]IMG_20231203_142140.jpg2025-05-06 14:18 2.7M 
[IMG]IMG_20231213_091601.jpg2025-05-06 14:18 3.9M 
[IMG]IMG_20231225_114830.jpg2025-05-06 14:18 8.8M 
[IMG]IMG_20231226_134633152.jpg2025-05-06 14:18 5.4M 
[ ]Ilumya-pm-en-pristine-Ctrl-259259-non-annotated-Level-III.pdf2025-05-06 14:18 554K 
[ ]Ilumya-pm-fr-pristine-Ctrl-259259-non-annotated-Level-III.pdf2025-05-06 14:18 660K 
[ ]Non-binding-indication-of-interest-to-acquire-shares-of-Taro-Pharmaceutical.pdf2025-05-06 14:18 875K 
[ ]Response-to-BSE-04122023.pdf2025-05-06 14:18 876K 
[ ]SEIntimation-1.pdf2025-05-06 14:18 1.0M 
[ ]SEIntimation.pdf2025-05-06 14:18 870K 
[ ]SEintimationforCTW.pdf2025-05-06 14:18 863K 
[ ]SPIL-Familiarization-Program-2023-24_Dec-2023.pdf2025-05-06 14:18 79K 
[ ]Sun-Pharma-Netherlands-B.V.-Formerly-known-as-Ranbaxy-Netherlands-B.V..pdf2025-05-06 14:18 2.5M 
[ ]Tablet-Image.pdf2025-05-06 14:18 242K 
[ ]Websit-upload-file-Softdeal-pharma..pdf2025-05-06 14:18 9.2M 
[IMG]WhatsApp-Image-2023-12-12-at-5.15.34-PM-imageonline.co-merged.jpeg2025-05-06 14:18 1.8M 
[ ]closure-of-sun-pharma-esop-trust.pdf2025-05-06 14:18 1.9M 
[ ]intimation-of-changes-in-senior-management-personnel.pdf2025-05-06 14:18 651K 
[ ]licensing-agreement-with-aclaris-therapeutics-inc.pdf2025-05-06 14:18 571K 
Apache/2.4.52 (Ubuntu) Server at sunpharma.com Port 80